Colorectal cancer management in the United Kingdom: Current practice and challenges

European Journal of Health Economics

Volumn 10, Issue SUPPL. 1, 2009, Pages

  Schurer, Willemien ^a   Kanavos, Panos ^a  

^a LONDON SCHOOL OF ECONOMICS   (United Kingdom)

Author keywords

Cancer management; Colorectal cancer; Screening; Treatment guidelines

Indexed keywords

BEVACIZUMAB; CAPECITABINE; CETUXIMAB; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN; TEGAFUR; URACIL;

AGING; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SCREENING; CANCER STAGING; CANCER STATISTICS; CANCER SURGERY; CANCER SURVIVAL; CLINICAL PRACTICE; COLORECTAL CANCER; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE PLANNING; HUMAN; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SURVIVAL RATE; UNITED KINGDOM;

EID: 76649125197     PISSN: 16187598     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10198-009-0202-1     Document Type: Conference Paper

References (26)

1. F Bray R Sankila J Ferlay, et al. 2002 Estimates of cancer incidence and mortality in Europe in 1995 Eur. J. Cancer 38 99 166 10.1016/S0959-8049(01) 00350-1 (Pubitemid 34031832)
2. Ferlay, J., Autier, P., Boniol, M., et al.: Estimates of the cancer incidence and mortality in Europe in 2006. Ann. Oncol. 18(3), 581-592 (2007) (Pubitemid 46359643)
3. Verdecchia, A., Francisci, S., Brenner, H., et al.: Recent cancer survival in Europe: a 2000-2002 period analysis of EUROCARE-4 data. Lancet Oncol. 8(9), 784-796 (2007) (Pubitemid 47321601)
4. M Sant T Aereleid F Berrino, et al. 2003 EUROCARE-3: survival of cancer patients diagnosed 1990-1994-results and commentary Ann. Oncol. 14 S5 v61 v118 10.1093/annonc/mdg754 (Pubitemid 46417464)
5. F Charaton 2004 Bowel cancer survival rates vary across England BMJ 328 974
6. Smith, J.J., Cornish, J., Tekkis, P.P., et al.: The national bowel cancer audit project 2007. Quality improvement and open reporting. Association of Coloproctology of Great Britain and Ireland (2007)
7. UK CRC Screening Pilot Evaluation Team: Evaluation of the UK colorectal cancer screening pilot, final report (2003)
8. National Health Service: The NHS cancer plan. A plan for investment. A plan for reform (2000)
9. Department of Health: Cancer reform strategy. ROCR reference 9092 (2007)
10. P Symonds 2007 National colorectal consensus group UK national colorectal cancer consensus meeting 2006 Clin. Oncol. 19 234 236 10.1016/j.clon.2007.02. 014 (Pubitemid 46547282)
11. Bowel Cancer UK: The bowel cancer screening programme. A progress report on the roll-out of screening in England (2007)
12. National Institute for Clinical Excellence: Improving outcomes in colorectal cancers. http://guidance.nice.org.uk/CSGCC/Guidance/pdf/English (2004)
13. J Price C Campbell J Sells, et al. 2005 Impact of UK colorectal cancer screening pilot on hospital diagnostic services J. Public Health 27 246 253 10.1093/pubmed/fdi030 (Pubitemid 41298084)
14. Swarbrick, E., Harnden, S., Hodson, R., et al.: Non-medical endoscopists. British society of Gastroenterologists. Guidelines in gastroenterology (2005)
15. JM Galloway J Gibson J Dalrymple 2002 Endoscopy in primary care-a survey of current practice Br. J. Gen. Practice 52 536 538
16. Healthcare Commission: Taking a closer look-endoscopy services in acute trusts (2007)
17. National Institute of Clinical Excellence: Laparoscopic surgery for colorectal cancer. NICE technology appraisal guidance 105. http://guidance.nice. org.uk/TA105/Guidance/pdf/English (2006)
18. Association of Coloproctology in Great Britain and Ireland: Guidelines for the management of colorectal cancer (3rd edn) (2007)
19. Airey, C., Becher, H., Erens, B., et al.: National surveys of NHS patients-national overview 1999/2000. London: Department of Health (2002)
20. National Health Service: Waiting times for cancer. Progress, lessons learned and next steps (2006)
21. Summers, E., Williams, M.: Re-audit of radiotherapy waiting times 2005. London: Royal College of Radiologists (2006)
22. Kanavos, P., Schurer, W., Owusu-Apenten, C., et al.: Colorectal cancer in Europe and Australia: challenges and opportunities for the future. London School of Economics (2008)
23. National Institute of Clinical Excellence: Capecitabine and oxaliplating in the adjuvant treatment of stage III colon cancer. NICE Technology Appraisal 100. http://guidance.nice.org.uk/TA100/Guidance/pdf/English (2006)
24. National Institute of Clinical Excellence: Guidance on the use of capecitabine and tegafur with uracil for metastatic colorectal cancer. NICE Technology Appraisal 61. http://guidance.nice.org.uk/TA61/Guidance/pdf/English (2003)
25. National Institute of Clinical Excellence: Irintotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer. NICE Technology Appraisal 93. http://guidance.nice.org.uk/TA93/Guidance/pdf/English (2005)
26. National Institute of Clinical Excellence: Bevacizumab and cetuximab for the treatment of metastatic colorectal cancer. NICE Technology Appraisal 118. http://guidance.nice.org.uk/TA118/Guidance/pdf/English (2007)